3 Patents
- US124417972025Anti-fc Ε-r1 Α (fcϵr1α) Antibodies, Bispecific Antigen-binding Molecules That Bind Fcϵr1α and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US119640162024Combination of IL-4/IL-13 Pathway Inhibitors and Plasma Cell Ablation for Treating Allergy
REGENERON PHARMACEUTICALS, Inc.
0 cites - US115781272023Anti-fc Epsilon-r1 Alpha (fcεr1α) Antibodies, Bispecific Antigen-binding Molecules That Bind Fcεr1α and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites